The Epidemiologic Studies project provides evaluation of human health effects associated with exposure to environmental contaminants in residents adjacent to a Superfund site in Sacramento, California by evaluating physiologic dysfunction. Specifically, reproductive and other hormone-related health effects will be ascertained in women residing downwind or in the groundwater plume of the Sacramento Superfund site. These rates of health effects will be compared to those in a similar, non-exposed nearby sample of women, and these rates will also be related to likelihood of exposure. In addition to interviewing women residing in these areas and in a comparison area, we will use serum and urine biomarkers of exposure and of health outcomes that have been developed in UC Davis laboratories. Thus far, this project has screened for eligibility over 850 women in the three study areas and has interviewed and assayed blood and urine from over 350 eligible women in the three areas. The three study areas appear comparable on a number of sociodemographic indicators, as well as on general community and women's health concerns (none of the top 5 of which include the Superfund site or endocrine/reproductive concerns, respectively). Further, we have observed no notable differences in thyroid hormone levels among the three study areas, as expected, since the relevant exposure that might have affected thyroid function ended in 1996, and no prolonged adverse effect on the thyroid would be expected. We have detected no evidence of environmental estrogens in any of the samples tested thus far (n=250). Some observed differences in reproductive health effects are suggestive, but further analyses with additional data are required to determine any differences in health effects that might have occurred during the times of likely exposure. Applications of epidemiologic techniques in this project will not only facilitate applications of the biomarkers in humans in the exposed population and assessment of the relation of exposure to environmental contaminants to human health effects, but will also illuminate modification of these effects by host and lifestyle factors. In turn, this project will contribute to the other projects by providing epidemiologic expertise for developing further field applications of techniques developed in the UCD laboratories in the future. In this effort, this project will be highly dependent on the various analytic projects, such as the Fate and Transport Project and Reproductive Biomarkers Project, as well as the Statistical Core to evaluate exposures to endocrine disrupters as a result of residing downwind or in the groundwater plume of a Superfund site, to assess the likely routes of exposure, and to assess the relation of such exposures to adverse reproductive and other endocrine health effects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
2P42ES004699-19
Application #
6900537
Study Section
Special Emphasis Panel (ZES1-SET-A (S4))
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
19
Fiscal Year
2005
Total Cost
$108,283
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications